Michael Schlag

671 total citations
29 papers, 507 citations indexed

About

Michael Schlag is a scholar working on Epidemiology, Hepatology and Neurology. According to data from OpenAlex, Michael Schlag has authored 29 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Neurology. Recurrent topics in Michael Schlag's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Michael Schlag is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Michael Schlag collaborates with scholars based in Austria, United States and Germany. Michael Schlag's co-authors include R. Hopf, Heinz Redl, Werner Sieghart, Michael L. Berger, Roman Furtmüller, Sigismund Huck, Kenneth A. Harris, Richard F. Potter, Udo Zifko and Oliver Lenz and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Journal of Hepatology.

In The Last Decade

Michael Schlag

28 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Schlag Austria	9	154	132	116	115	66	29	507
R. Demeyere Belgium	12	73 0.5×	37 0.3×	182 1.6×	5 0.0×	37 0.6×	29	585
Savaş Çelebi Türkiye	15	11 0.1×	83 0.6×	117 1.0×	68 0.6×	38 0.6×	30	501
Wayne Vanderkolk United States	14	16 0.1×	78 0.6×	205 1.8×	8 0.1×	18 0.3×	22	689
Muhammad U. Butt United States	12	38 0.2×	43 0.3×	167 1.4×	4 0.0×	10 0.2×	19	518
R. L. Swank United States	13	43 0.3×	54 0.4×	78 0.7×	3 0.0×	130 2.0×	24	492
Gautam Sreeram United States	13	134 0.9×	36 0.3×	153 1.3×	3 0.0×	19 0.3×	16	492
Iyad Khamaysi Israel	14	7 0.0×	47 0.4×	241 2.1×	42 0.4×	19 0.3×	56	675
Dorothee Decker Germany	9	8 0.1×	124 0.9×	225 1.9×	27 0.2×	22 0.3×	10	556
BJÖRN AMUNDSON Sweden	8	25 0.2×	62 0.5×	106 0.9×	11 0.1×	71 1.1×	12	407

Countries citing papers authored by Michael Schlag

Since Specialization

Citations

This map shows the geographic impact of Michael Schlag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schlag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schlag more than expected).

Fields of papers citing papers by Michael Schlag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schlag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schlag. The network helps show where Michael Schlag may publish in the future.

Co-authorship network of co-authors of Michael Schlag

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schlag. A scholar is included among the top collaborators of Michael Schlag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schlag. Michael Schlag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

D’Offizi, Gianpiero, Calogero Cammà, Chiara Taibi, et al.. (2017). Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection.. PubMed. 40(1). 19–26. 4 indexed citations

2.

Asselah, Tarik, Christophe Moreno, Christoph Sarrazin, et al.. (2017). Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response. PLoS ONE. 12(1). e0168713–e0168713. 6 indexed citations

3.

Mauss, Stefan, Michael Schlag, Isabelle Lonjon‐Domanec, et al.. (2017). Efficacy and safety of Simeprevir-containing hepatitis C therapy in patients on opiate substitution therapy. Journal of Hepatology. 66(1). S520–S521. 7 indexed citations

4.

Fehr, Jan, Dunja Nicca, Jean‐Christophe Goffard, et al.. (2016). Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape. Infection. 44(4). 521–529. 6 indexed citations

5.

Asselah, Tarik, Christophe Moreno, Christoph Sarrazin, et al.. (2016). An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1). PLoS ONE. 11(7). e0158526–e0158526. 4 indexed citations

6.

Fevery, Bart, Leen Vijgen, Veerle Van Eygen, et al.. (2016). Consistent Simeprevir Resistance Profile in Hepatitis C Virus Genotype 1-Infected Patients Failing Simeprevir Interferon-Free Compared with Interferon-Containing Regimens. Journal of Hepatology. 64(2). S399–S399. 2 indexed citations

7.

Sarrazin, Christoph, Erkki Lathouwers, Monika Peeters, et al.. (2015). Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region. Antiviral Research. 116. 10–16. 82 indexed citations

8.

Grabmeier‐Pfistershammer, Katharina, et al.. (2013). Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation. Wiener klinische Wochenschrift. 125(13-14). 402–407. 10 indexed citations

9.

Heiken, Hans, L Gallo, Michael Schlag, et al.. (2012). STRike ‐ characteristics of HIV‐1‐infected patients treated with a single‐tablet regimen in daily clinical practice. Journal of the International AIDS Society. 15(S4). 1–2. 1 indexed citations

10.

Schlag, Michael, R. Hopf, Udo Zifko, & Heinz Redl. (2002). Epileptic Seizures Following Cortical Application of Fibrin Sealants Containing Tranexamic Acid in Rats. Acta Neurochirurgica. 144(1). 63–69. 40 indexed citations

11.

Furtmüller, Roman, Michael Schlag, Michael L. Berger, et al.. (2002). Tranexamic Acid, a Widely Used Antifibrinolytic Agent, Causes Convulsions by a γ-Aminobutyric AcidA Receptor Antagonistic Effect. Journal of Pharmacology and Experimental Therapeutics. 301(1). 168–173. 147 indexed citations

12.

Hopf, R., et al.. (2002). The effect of ketamine/xylazine anesthesia on sensory and motor evoked potentials in the rat. Spinal Cord. 41(1). 16–22. 47 indexed citations

13.

Aharinejad, Seyedhossein, et al.. (2002). EFFICIENT CARBOPLATIN SINGLE THERAPY IN A MOUSE MODEL OF HUMAN TESTICULAR NONSEMINOMATOUS GERM CELL TUMOR. The Journal of Urology. 368–374. 1 indexed citations

14.

Schlag, Michael, R. Hopf, & Heinz Redl. (2002). Hind Limb Hyperexcitability Following the Application of Fibrin Sealants Containing Tranexamic Acid to the Lumbar Spinal Cord in Rats. European Journal of Trauma. 28(4). 252–257. 1 indexed citations

15.

Schlag, Michael, Kenneth A. Harris, & Richard F. Potter. (2001). Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle. American Journal of Physiology-Heart and Circulatory Physiology. 280(4). H1716–H1721. 23 indexed citations

16.

Schlag, Michael. (2001). Convulsive Seizures Following Subdural Application of Fibrin Sealant Containing Tranexamic Acid in a Rat Model. Neurosurgery. 49(2). 480–480. 1 indexed citations

17.

Schlag, Michael, R. Hopf, & Heinz Redl. (2000). Convulsive Seizures Following Subdural Application of Fibrin Sealant Containing Tranexamic Acid in a Rat Model. Neurosurgery. 47(6). 1463–1467. 60 indexed citations

18.

Schlag, Michael, R. Hopf, & Heinz Redl. (2000). Convulsive Seizures Following Subdural Application of Fibrin Sealant Containing Tranexamic Acid in a Rat Model. Neurosurgery. 47(6). 1463–1467. 8 indexed citations

19.

Schlag, Michael, Sharon E. Clarke, Michael W. Carson, Kenneth A. Harris, & Richard F. Potter. (1999). The effect of mannitol versus dimethyl thiourea at attenuating ischemia/reperfusion-induced injury to skeletal muscle. Journal of Vascular Surgery. 29(3). 511–521. 9 indexed citations

20.

Schlag, Michael, R. Hopf, & Heinz Redl. (1999). RECORDING OF CORTICALLY AND BRAINSTEM EVOKED MUSCLE POTENTIALS IN A CHRONIC RAT MODEL.. Shock. 12(Supplement). 3–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact